D9175

Dantrolene sodium salt

Ca2+ release from sarcoplasmic reticulum inhibitor, solid

• Synonyma: 1-[(5-­(p-Nitro­phenyl)­fur­furyl­idene)­amino]­hydan­toin sodium salt
• Empirický vzorec (Hillův zápis): C₁₄H₉N₄NaO₅
• Číslo CAS: 14663-23-1
• Molekulová hmotnost: 336.23
• UNSPSC Code: 12352200
• PubChem Substance ID: 24278823
• NACRES: NA.77
• MDL number: MFCD00079130
• Form: solid

Vlastnosti

• Název produktu: Dantrolene sodium salt,
• form: solid
• Quality Segment: 200
• originator: JHP Pharmaceuticals
• SMILES string: [Na+].[H]\C(=N/N1CC(=O)N=C1[O-])c2ccc(o2)-c3ccc(cc3)[N+]([O-])=O
• InChI: 1S/C14H10N4O5.Na/c19-13-8-17(14(20)16-13)15-7-11-5-6-12(23-11)9-1-3-10(4-2-9)18(21)22;/h1-7H,8H2,(H,16,19,20);/q;+1/p-1/b15-7+;
• InChI key: KSRLIXGNPXAZHD-HAZZGOGXSA-M
• Gene Information: human ... RYR1(6261), RYR3(6263)

Popis

Biochem/physiol Actions

Inhibitor of Ca²⁺ release from sarcoplasmic reticulum; muscle relaxant.

Features and Benefits

This compound is featured on the InsP3/Ryanodine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by JHP Pharmaceuticals. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Other Notes

2024 CiteAb Award Winner for Supplier Succeeding in Parkinson′s Research

Bezpečnostní informace

• Skladovací třída: 11 - Combustible Solids
• wgk: WGK 2
• flash_point_f: Not applicable
• flash_point_c: Not applicable